In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65

To replace mechanical ventilation (MV), which represents the cornerstone therapy in severe COVID-19 cases, high-flow nasal oxygen (HFNO) therapy has recently emerged as a less-invasive therapeutic possibility for those patients. Respecting the risk of MV delay as a result of HFNO use, we aimed to ev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Life (Basel, Switzerland) Jg. 11; H. 8; S. 735
Hauptverfasser:	Kljakovic Gaspic, Toni, Pavicic Ivelja, Mirela, Kumric, Marko, Matetic, Andrija, Delic, Nikola, Vrkic, Ivana, Bozic, Josko
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 23.07.2021 MDPI
Schlagworte:	Biomarkers Chronic illnesses COVID-19 Evaluation HFNO in-hospital outcomes Mechanical ventilation Mortality Multivariate analysis Oxygen Patients Risk risk scores Subgroups Ventilators COVID-19 mechanical ventilation risk scores HFNO in-hospital outcomes
ISSN:	2075-1729, 2075-1729
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!